Form 8-K - Current report:
SEC Accession No. 0001558370-21-002259
Filing Date
2021-03-02
Accepted
2021-03-02 16:16:28
Documents
14
Period of Report
2021-03-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20210302x8k.htm   iXBRL 8-K 44311
2 EX-99.1 glyc-20210302xex99d1.htm EX-99.1 162557
3 GRAPHIC glyc-20210302xex99d1001.jpg GRAPHIC 7194
  Complete submission text file 0001558370-21-002259.txt   350380

Data Files

Seq Description Document Type Size
4 EX-101.SCH glyc-20210302.xsd EX-101.SCH 3222
5 EX-101.LAB glyc-20210302_lab.xml EX-101.LAB 15497
6 EX-101.PRE glyc-20210302_pre.xml EX-101.PRE 10516
7 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20210302x8k_htm.xml XML 4618
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 21703802
SIC: 2834 Pharmaceutical Preparations